SCHEMBL229379

SCHEMBL229379

OCC1(O)COC(O)(CO)CO1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.35
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL407 1.00 EPHX1 (0.35) EPHX1KDM4EALDH1A1MAPT
SCHEMBL17269701 0.83 EPHX1 (0.36) EPHX1
SCHEMBL16482373 0.83 EPHX1 (0.36) EPHX1
SCHEMBL23872252 0.81 EPHX1 (0.30) EPHX1
SCHEMBL13376018 0.78
SCHEMBL8145941 0.75
SCHEMBL12257877 0.73
SCHEMBL13967198 0.71
SCHEMBL6579137 0.71
SCHEMBL18654164 0.69 KDM4E (0.30) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001850-A1 NOVEL IMIDAZOLE COMPOUNDS, PROCESS FOR THE SYNTHESIS AND USES THEREOF AHAMMUNE BIOSCIENCES PRIVATE LTD (IN) 2026-01-01 US claimed
US-12378203-B2 Imidazole compounds, process for the synthesis and uses thereof AHAMMUNE BIOSCIENCES PRIVATE LIMITED (IN) 2025-08-05 US claimed
CN-111592546-B Preparation method of adestat 上海鲲博玖瑞医药科技发展有限公司 2023-08-25 CN claimed
CN-115404039-B Polyurethane adhesive and preparation method and application thereof 杭州之江有机硅化工有限公司 2023-06-16 CN claimed
CN-114524882-B Method for improving hydrolysis rate of carbohydrate polymer in solution containing cupric salt 中国科学院大连化学物理研究所 2023-03-14 CN claimed
CN-115404039-A Polyurethane adhesive and preparation method and application thereof 杭州之江有机硅化工有限公司 2022-11-29 CN claimed
CN-113321663-B Main chain degradable photoresist resin monomer synthesized from 1, 3-dihydroxyacetone dimer and synthesis method and application thereof 徐州博康信息化学品有限公司 2022-07-22 CN claimed
CN-114524882-A Method for improving hydrolysis rate of carbohydrate polymer in solution containing cupric salt 中国科学院大连化学物理研究所 2022-05-24 CN claimed
US-20120001134-A1 LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS PLEOTINT, LLC (US) 2012-01-05 US claimed
US-20110318292-A1 ENVIRONMENTALLY BENIGN PLASTICIZERS BASED ON DERIVATIVES OF ACETONE BOSTON POLYMER LLC (US) 2011-12-29 US claimed
US-20090283728-A1 LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS PLEOTINT, LLC (US) 2009-11-19 US claimed
EP-2082005-A1 LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS Pleotint, L.L.C. (US) 2009-07-29 EP claimed
US-20080100902-A1 LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS PLEOTINT, LLC (US) 2008-05-01 US claimed
WO-2008028128-A1 LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS PLEOTINT, L.L.C. (US) 2008-03-06 WO claimed
US-12594339-B2 Lipid prodrugs of JAK inhibitors and uses thereof SEAPORT THERAPEUTICS, INC. (US) 2026-04-07 US disclosed
US-12528781-B2 Heterocyclic GLP-1 agonists GASHERBRUM BIO, INC. (US) 2026-01-20 US disclosed
CN-121320012-A Food-grade cutting fluid for glass processing and preparation method thereof 东莞市索拉润滑油科技有限公司 2026-01-13 CN disclosed
US-5382709-A IMMUNOSTIMULANTS, VIRICIDES AND ANTIMETASTATIC AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1995-01-17 US disclosed
US-5240707-A 2,3,4-trihydroxy-5-(hydroxymethyl)cyclopentylamines used as immunostimulants, viricides and antimetastasis agents MERRELL DOW PHARMACEUTICALS INC. 1993-08-31 US disclosed
EP-0451834-A2 Alpha-mannosidase and fucosidase inhibitors MERRELL PHARMACEUTICALS INC. (US) 1991-10-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001850-A1 NOVEL IMIDAZOLE COMPOUNDS, PROCESS FOR THE SYNTHESIS AND USES THEREOF MALT1, ADRM1, CYP11B1 EPHX1 3402/4885KDM4E 4085/4885ALDH1A1 2523/4885
US-20110318292-A1 ENVIRONMENTALLY BENIGN PLASTICIZERS BASED ON DERIVATIVES OF ACETONE HAO2, HAO1, GNPAT EPHX1 499/4885KDM4E 4166/4885ALDH1A1 47/4885
US-12528781-B2 Heterocyclic GLP-1 agonists GLP1R, GIPR, VIP EPHX1 4851/4885KDM4E 2887/4885ALDH1A1 3780/4885
US-12378203-B2 Imidazole compounds, process for the synthesis and uses thereof IDO1, IDO2, NFATC1 EPHX1 1597/4885KDM4E 841/4885ALDH1A1 495/4885
US-12594339-B2 Lipid prodrugs of JAK inhibitors and uses thereof JAK1, JAK3, JAK2 EPHX1 2445/4885KDM4E 681/4885ALDH1A1 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.